CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas

Immunohistochemical Expression of CD105 and TGF-β1 in Oral Squamous Cell Carcinoma and Adjacent Apparently Normal Oral Mucosa and its Correlation With Clinicopathologic Features

(2016) Sindhu Nair et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

The Evolving Molecular Genetics of Low-grade Glioma

(2015) Sriram Venneti et al.   ADVANCES IN ANATOMIC PATHOLOGY

Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma

(2015) Dimitrios Lytras et al.   PANCREAS

Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression

(2014) Juliana Passos Paschoal et al.   BMC CANCER

Effects of the combination of TRC105 and bevacizumab on endothelial cell biology

(2014) Yingmiao Liu et al.   INVESTIGATIONAL NEW DRUGS

CD105 (Endoglin) Is Highly Overexpressed in a Subset of Cases of Acute Myeloid Leukemias

(2013) Zaher I. Chakhachiro et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Endoglin for tumor imaging and targeted cancer therapy

(2013) Madelon Paauwe et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

IDH1-Associated Primary Glioblastoma in Young Adults Displays Differential Patterns of Tumour and Vascular Morphology

(2013) Sergey Popov et al.   PLoS One

CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma

(2012) Stuart J. Smith et al.   ACTA NEUROPATHOLOGICA

Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105

(2011) Laurence M. Wood et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth

(2011) Roselyne Castonguay et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Matrix Metalloproteinase-14 (MT1-MMP)-Mediated Endoglin Shedding Inhibits Tumor Angiogenesis

(2010) L. J. A. C. Hawinkels et al.   CANCER RESEARCH